Dr. Kimystian Harrison, MD, is a Sylvia Lawry Fellow, funded by the Society. The Sylvia Lawrey Fellowship program provides an individual with an MD or equivalent medical degree with up to 3 years of formal training under the tutelage of an established investigator, in key elements associated with conducting clinical trials in MS.“While we wait for a cure, my research is focused on enriching the lives of those living with MS as much as I possibly can,” Harrison said.She pointed out that there is a disparity in the health outcomes of people living with MS based on their race. Black adults with MS experience advanced disease progression and worse overall health outcomes compared to white adults, and the reason is unclear. Some of her research has aimed to fill this gap by exploring the differences in racial and social factors among people living with MS and their effects on the healthcare experience.“From one study, we found that Black people reported more medical mistrust than white people. And Black adults living in socioeconomically advantaged areas still reported more discrimination by their healthcare providers – with significant effects,” Harrison said.Even without socioeconomic barriers, racial factors still lead to medical mistrust, which is a barrier to healthcare for minority groups, an issue that requires more attention in the MS community.“In order to bring new treatments to everyone living with MS and stop disease progression in its tracks, we need representation among our clinical trial participants. We need more research like the CHIMES (Characterization of Ocrelizumab in Minorities with Multiple Sclerosis), trial I’m involved in that’s studying the effects of ocrelizumab specifically in minorities living with MS. And to encourage participation in this research, we need to create trust among all populations living with MS,” Harrison said.This research is just a snapshot of the groundbreaking work that is not only bringing us closer to a cure, but enriching experiences, improving the quality of healthcare and empowering everyone living with MS to take back control.